TY - JOUR
T1 - Cryo-EM structures of human coagulation factors V and Va
AU - Ruben, Eliza A.
AU - Rau, Michael J.
AU - Fitzpatrick, James A.J.
AU - Di Cera, Enrico
N1 - Funding Information:
This study was supported, in part, by National Institutes of Health (NIH), National Heart, Lung, and Blood Institute grants HL049413, HL139554, and HL147821 (E.D.C.). M.J.R. and J.A.J.F. are supported by the Washington University Center for Cellular Imaging, which is funded, in part, by Washington University School of Medicine, the Children's Discovery Institute of Washington University, and St Louis Children's Hospital (grants CDI-CORE-2015-505 and CDI-CORE-2019-813); the Foundation for Barnes-Jewish Hospital (grant 3770); the Washington University Diabetes Research Center (NIH, National Institute of Diabetes and Digestive and Kidney Diseases grant DK020579); and The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine (NIH, National Cancer Institute grant CA091842).
Publisher Copyright:
© 2021 American Society of Hematology
PY - 2021/6/3
Y1 - 2021/6/3
N2 - Coagulation factor V (fV) is the precursor of fVa, which, together with fXa, Ca2+, and phospholipids, defines the prothrombinase complex and activates prothrombin in the penultimate step of the coagulation cascade. We solved the cryogenic electron microscopy (cryo-EM) structures of human fV and fVa at atomic (3.3 Å) and near-atomic (4.4 Å) resolution, respectively. The structure of fV reveals the entire A1-A2-B-A3-C1-C2 assembly, but with a surprisingly disordered B domain. The C1 and C2 domains provide a platform for interaction with phospholipid membranes and support the A1 and A3 domains, with the A2 domain sitting on top of them. The B domain is highly dynamic and visible only for short segments connecting to the A2 and A3 domains. The A2 domain reveals all sites of proteolytic processing by thrombin and activated protein C, a partially buried epitope for binding fXa, and fully exposed epitopes for binding activated protein C and prothrombin. Removal of the B domain and activation to fVa exposes the sites of cleavage by activated protein C at R306 and R506 and produces increased disorder in the A1-A2-A3-C1-C2 assembly, especially in the C-terminal acidic portion of the A2 domain that is responsible for prothrombin binding. Ordering of this region and full exposure of the fXa epitope emerge as necessary steps in the assembly of the prothrombin-prothrombinase complex. These structures offer molecular context for the function of fV and fVa and pioneer the analysis of coagulation factors by cryo-EM.
AB - Coagulation factor V (fV) is the precursor of fVa, which, together with fXa, Ca2+, and phospholipids, defines the prothrombinase complex and activates prothrombin in the penultimate step of the coagulation cascade. We solved the cryogenic electron microscopy (cryo-EM) structures of human fV and fVa at atomic (3.3 Å) and near-atomic (4.4 Å) resolution, respectively. The structure of fV reveals the entire A1-A2-B-A3-C1-C2 assembly, but with a surprisingly disordered B domain. The C1 and C2 domains provide a platform for interaction with phospholipid membranes and support the A1 and A3 domains, with the A2 domain sitting on top of them. The B domain is highly dynamic and visible only for short segments connecting to the A2 and A3 domains. The A2 domain reveals all sites of proteolytic processing by thrombin and activated protein C, a partially buried epitope for binding fXa, and fully exposed epitopes for binding activated protein C and prothrombin. Removal of the B domain and activation to fVa exposes the sites of cleavage by activated protein C at R306 and R506 and produces increased disorder in the A1-A2-A3-C1-C2 assembly, especially in the C-terminal acidic portion of the A2 domain that is responsible for prothrombin binding. Ordering of this region and full exposure of the fXa epitope emerge as necessary steps in the assembly of the prothrombin-prothrombinase complex. These structures offer molecular context for the function of fV and fVa and pioneer the analysis of coagulation factors by cryo-EM.
UR - http://www.scopus.com/inward/record.url?scp=85107713969&partnerID=8YFLogxK
U2 - 10.1182/blood.2021010684
DO - 10.1182/blood.2021010684
M3 - Article
C2 - 33684942
AN - SCOPUS:85107713969
SN - 0006-4971
VL - 137
SP - 3137
EP - 3144
JO - Blood
JF - Blood
IS - 22
ER -